Lataa...
SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention
The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a high-risk viral agent involved in the recent pandemic stated worldwide by the World Health Organization. The infection is correlated to a severe systemic and respiratory disease in many cases, which is clinically treated with a mu...
Tallennettuna:
| Julkaisussa: | Microorganisms |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7999785/ https://ncbi.nlm.nih.gov/pubmed/33806624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/microorganisms9030525 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|